{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:18:53Z","timestamp":1791310733903,"version":"4.3.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome Trust Senior Fellow in Clinical Science","award":["101876\/Z\/13\/Z"],"award-info":[{"award-number":["101876\/Z\/13\/Z"]}]},{"name":"UK NIHR Senior Investigator"},{"name":"Medical Research Council"},{"name":"Mitochondrial Biology Unit","award":["MC_UP_1501\/2"],"award-info":[{"award-number":["MC_UP_1501\/2"]}]},{"DOI":"10.13039\/501100013372","name":"Wellcome Trust Centre for Mitochondrial Research","doi-asserted-by":"crossref","award":["096919Z\/11\/Z"],"award-info":[{"award-number":["096919Z\/11\/Z"]}],"id":[{"id":"10.13039\/501100013372","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council (UK) Centre for Translational Muscle Disease Research","award":["G0601943"],"award-info":[{"award-number":["G0601943"]}]},{"name":"EU FP7 TIRCON"},{"name":"National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust"},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.15252\/emmm.201505079","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T21:38:56Z","timestamp":1448573936000},"page":"1503-1512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Mitochondrial disease in adults: what's old and what's new?"],"prefix":"10.1038","volume":"7","author":[{"given":"Patrick F","family":"Chinnery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"BFEMMM201505079_CR1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.expneurol.2009.09.026","volume":"220","author":"MV Alavi","year":"2009","unstructured":"Alavi MV, Fuhrmann N, Nguyen HP, Yu\u2010Wai\u2010Man P, Heiduschka P, Chinnery PF, Wissinger B (2009) Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Exp Neurol 220: 404\u2013409","journal-title":"Exp Neurol"},{"key":"BFEMMM201505079_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo\u2010Kottler B, Auburger G et\u00a0al (2000) OPA1, encoding a dynamin\u2010related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26: 211\u2013215","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","volume":"131","author":"P Amati\u2010Bonneau","year":"2008","unstructured":"Amati\u2010Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, Campos Y, Rivera H, de la Aleja JG, Carroccia R et\u00a0al (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u201cplus\u201d phenotypes. Brain 131: 338\u2013351","journal-title":"Brain"},{"key":"BFEMMM201505079_CR4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/humu.22393","volume":"34","author":"E Baruffini","year":"2013","unstructured":"Baruffini E, Dallabona C, Invernizzi F, Yarham JW, Melchionda L, Blakely EL, Lamantea E, Donnini C, Santra S, Vijayaraghavan S et\u00a0al (2013) MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum Mutat 34: 1501\u20131509","journal-title":"Hum Mutat"},{"key":"BFEMMM201505079_CR5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ehjci\/jes226","volume":"14","author":"MG Bates","year":"2013","unstructured":"Bates MG, Hollingsworth KG, Newman JH, Jakovljevic DG, Blamire AM, Macgowan GA, Keavney BD, Chinnery PF, Turnbull DM, Taylor RW et\u00a0al (2013) Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers. Eur Heart J Cardiovasc Imaging 14: 650\u2013658","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"BFEMMM201505079_CR6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/421530","volume":"74","author":"Y Bykhovskaya","year":"2004","unstructured":"Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel\u2010Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74: 1303\u20131308","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.24410","volume":"78","author":"V Carelli","year":"2015","unstructured":"Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, Porcelli AM, Rugolo M, Valentino ML, Iommarini L et\u00a0al (2015) Syndromic parkinsonism and dementia associated with OPA1 missense mutations. Ann Neurol 78: 21\u201338","journal-title":"Ann Neurol"},{"key":"BFEMMM201505079_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","volume":"93","author":"G Casari","year":"1998","unstructured":"Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R et\u00a0al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear\u2010encoded mitochondrial metalloprotease. Cell 93: 973\u2013983","journal-title":"Cell"},{"key":"BFEMMM201505079_CR9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","volume":"48","author":"PF Chinnery","year":"2000","unstructured":"Chinnery PF, Johnson MA, Wardell TM, Singh\u2010Kler R, Hayes C, Brown DT, Taylor RW, Bindoff LA, Turnbull DM (2000) Epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 48: 188\u2013193","journal-title":"Ann Neurol"},{"key":"BFEMMM201505079_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.75","volume":"49","author":"N Darin","year":"2001","unstructured":"Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol 49: 377\u2013383","journal-title":"Ann Neurol"},{"key":"BFEMMM201505079_CR11","doi-asserted-by":"crossref","first-page":"41851","DOI":"10.1074\/jbc.M112.391151","volume":"287","author":"CE Dieteren","year":"2012","unstructured":"Dieteren CE, Koopman WJ, Swarts HG, Peters JG, Maczuga P, van Gemst JJ, Masereeuw R, Smeitink JA, Nijtmans LG, Willems PH (2012) Subunit\u2010specific incorporation efficiency and kinetics in mitochondrial complex I homeostasis. J Biol Chem 287: 41851\u201341860","journal-title":"J Biol Chem"},{"key":"BFEMMM201505079_CR12","doi-asserted-by":"crossref","first-page":"101E","DOI":"10.1308\/003588414X13824511649733","volume":"96","author":"S Dindyal","year":"2014","unstructured":"Dindyal S, Mistry K, Angamuthu N, Smith G, Hilton D, Arumugam P, Mathew J (2014) MELAS syndrome presenting as an acute surgical abdomen. Ann R Coll Surg Engl 96: 101E\u2013103E","journal-title":"Ann R Coll Surg Engl"},{"key":"BFEMMM201505079_CR13","doi-asserted-by":"crossref","first-page":"20815","DOI":"10.1074\/jbc.M115.641498","volume":"290","author":"MM Elguindy","year":"2015","unstructured":"Elguindy MM, Nakamaru\u2010Ogiso E (2015) Apoptosis\u2010inducing factor (AIF) and its family member protein, AMID, are rotenone\u2010sensitive NADH: ubiquinone oxidoreductases (NDH\u20102). J Biol Chem 290: 20815\u201320826","journal-title":"J Biol Chem"},{"key":"BFEMMM201505079_CR14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","volume":"83","author":"HR Elliott","year":"2008","unstructured":"Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83: 254\u2013260","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fgene.2015.00134","volume":"6","author":"E Fernandez\u2010Vizarra","year":"2015","unstructured":"Fernandez\u2010Vizarra E, Zeviani M (2015) Nuclear gene mutations as the cause of mitochondrial complex III deficiency. Front Genet 6: 134","journal-title":"Front Genet"},{"key":"BFEMMM201505079_CR16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","volume":"137","author":"AR Foley","year":"2014","unstructured":"Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al\u2010Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J et\u00a0al (2014) Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain 137: 44\u201356","journal-title":"Brain"},{"key":"BFEMMM201505079_CR17","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.febslet.2015.08.006","volume":"589","author":"M Fujikawa","year":"2015","unstructured":"Fujikawa M, Sugawara K, Tanabe T, Yoshida M (2015) Assembly of human mitochondrial ATP synthase through two separate intermediates, F\u2010c\u2010ring and b\u2010e\u2010g complex. FEBS Lett 589: 2707\u20132712","journal-title":"FEBS Lett"},{"key":"BFEMMM201505079_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2796.2003.01095.x","volume":"253","author":"A Garcia\u2010Velasco","year":"2003","unstructured":"Garcia\u2010Velasco A, Gomez\u2010Escalonilla C, Guerra\u2010Vales JM, Cabello A, Campos Y, Arenas J (2003) Intestinal pseudo\u2010obstruction and urinary retention: cardinal features of a mitochondrial DNA\u2010related disease. J Intern Med 253: 381\u2013385","journal-title":"J Intern Med"},{"key":"BFEMMM201505079_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ejhg.2014.96","volume":"23","author":"K Gardner","year":"2015","unstructured":"Gardner K, Payne BA, Horvath R, Chinnery PF (2015) Use of stereotypical mutational motifs to define resolution limits for the ultra\u2010deep resequencing of mitochondrial DNA. Eur J Hum Genet 23: 413\u2013415","journal-title":"Eur J Hum Genet"},{"key":"BFEMMM201505079_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4614-3573-0_4","volume":"748","author":"D Ghezzi","year":"2012","unstructured":"Ghezzi D, Zeviani M (2012) Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology. Adv Exp Med Biol 748: 65\u2013106","journal-title":"Adv Exp Med Biol"},{"key":"BFEMMM201505079_CR21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2015.03.001","volume":"25","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Elson JL, Newman J, Payne B, McFarland R, Newton JL, Turnbull DM (2015a) Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul Disord 25: 563\u2013566","journal-title":"Neuromuscul Disord"},{"key":"BFEMMM201505079_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamaneurol.2014.1753","volume":"72","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Pfeffer G, Griffin H, Blakely EL, Kurzawa\u2010Akanbi M, Gabriel J, Sitarz K, Roberts M, Schoser B, Pyle A et\u00a0al (2015b) Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28. JAMA Neurol 72: 106\u2013111","journal-title":"JAMA Neurol"},{"key":"BFEMMM201505079_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu\u2010Wai\u2010Man P, Chinnery PF et\u00a0al (2015c) Prevalence of nuclear and mtDNA mutations related to adult mitochondrial disease. Ann Neurol 77: 753\u2013759","journal-title":"Ann Neurol"},{"key":"BFEMMM201505079_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","volume":"88","author":"A Gotz","year":"2011","unstructured":"Gotz A, Tyynismaa H, Euro L, Ellonen P, Hyotylainen T, Ojala T, Hamalainen RH, Tommiska J, Raivio T, Oresic M et\u00a0al (2011) Exome sequencing identifies mitochondrial alanyl\u2010tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88: 635\u2013642","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/brain\/awt321","volume":"137","author":"JP Grady","year":"2014","unstructured":"Grady JP, Campbell G, Ratnaike T, Blakely EL, Falkous G, Nesbitt V, Schaefer AM, McNally RJ, Gorman GS, Taylor RW et\u00a0al (2014) Disease progression in patients with single, large\u2010scale mitochondrial DNA deletions. Brain 137: 323\u2013334","journal-title":"Brain"},{"key":"BFEMMM201505079_CR26","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1093\/hmg\/ddn280","volume":"17","author":"AH Hakonen","year":"2008","unstructured":"Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, Lampinen M, Sajantila A, Lonnqvist T, Spelbrink JN et\u00a0al (2008) Infantile\u2010onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17: 3822\u20133835","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201505079_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cmet.2014.07.001","volume":"20","author":"BM Hallberg","year":"2014","unstructured":"Hallberg BM, Larsson NG (2014) Making proteins in the powerhouse. Cell Metab 20: 226\u2013240","journal-title":"Cell Metab"},{"key":"BFEMMM201505079_CR28","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/brain\/awv226","volume":"138","author":"JP Halter","year":"2015","unstructured":"Halter JP, Michael W, Schupbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M et\u00a0al (2015) Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 138: 2847\u20132858","journal-title":"Brain"},{"key":"BFEMMM201505079_CR29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.nmd.2012.03.001","volume":"22","author":"KG Hollingsworth","year":"2012","unstructured":"Hollingsworth KG, Gorman GS, Trenell MI, McFarland R, Taylor RW, Turnbull DM, MacGowan GA, Blamire AM, Chinnery PF (2012) Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load. Neuromuscul Disord 22: 592\u2013596","journal-title":"Neuromuscul Disord"},{"key":"BFEMMM201505079_CR30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/331717a0","volume":"331","author":"I Holt","year":"1988","unstructured":"Holt I, Harding AE, Morgan\u2010Hughes JA (1988) Deletion of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717\u2013719","journal-title":"Nature"},{"key":"BFEMMM201505079_CR31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1086\/302049","volume":"63","author":"N Howell","year":"1998","unstructured":"Howell N, Mackey DA (1998) Low\u2010penetrance branches in matrilineal pedigrees with Leber Hereditary Optic Neuropathy. Am J Hum Genet 63: 1220\u20131224","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","volume":"131","author":"G Hudson","year":"2008","unstructured":"Hudson G, Amati\u2010Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, Griffiths PG, Ahlqvist K, Suomalainen A, Reynier P et\u00a0al (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131: 329\u2013337","journal-title":"Brain"},{"key":"BFEMMM201505079_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/brain\/118.2.339","volume":"118","author":"MJ Jackson","year":"1995","unstructured":"Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118: 339\u2013357","journal-title":"Brain"},{"key":"BFEMMM201505079_CR34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ajhg.2012.08.020","volume":"91","author":"A Janer","year":"2012","unstructured":"Janer A, Antonicka H, Lalonde E, Nishimura T, Sasarman F, Brown GK, Brown RM, Majewski J, Shoubridge EA (2012) An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet 91: 737\u2013743","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","volume":"181","author":"P Kabunga","year":"2015","unstructured":"Kabunga P, Lau AK, Phan K, Puranik R, Liang C, Davis RL, Sue CM, Sy RW (2015) Systematic review of cardiac electrical disease in Kearns\u2010Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 181: 303\u2013310","journal-title":"Int J Cardiol"},{"key":"BFEMMM201505079_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archneurol.2008.526","volume":"66","author":"P Kaufmann","year":"2009","unstructured":"Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V, Koenigsberger DY, Pascual JM, Sano M, Hirano M et\u00a0al (2009) Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66: 85\u201391","journal-title":"Arch Neurol"},{"key":"BFEMMM201505079_CR37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.289.5480.782","volume":"289","author":"J Kaukonen","year":"2000","unstructured":"Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP, Keranen S, Peltonen L, Suomalainen A (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289: 782\u2013785","journal-title":"Science"},{"key":"BFEMMM201505079_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/brain\/awq320","volume":"134","author":"JP Kemp","year":"2011","unstructured":"Kemp JP, Smith PM, Pyle A, Neeve VC, Tuppen HA, Schara U, Talim B, Topaloglu H, Holinski\u2010Feder E, Abicht A et\u00a0al (2011) Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 134: 183\u2013195","journal-title":"Brain"},{"key":"BFEMMM201505079_CR39","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu\u2010Wai\u2010Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A et\u00a0al (2011) A randomized placebo\u2010controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 134: 2677\u20132686","journal-title":"Brain"},{"key":"BFEMMM201505079_CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000000578","volume":"83","author":"S Koene","year":"2014","unstructured":"Koene S, de Laat P, van Tienoven DH, Vriens D, Brandt AM, Sweep FC, Rodenburg RJ, Donders AR, Janssen MC, Smeitink JA (2014) Serum FGF21 levels in adult m.3243A>G carriers: clinical implications. Neurology 83: 125\u2013133","journal-title":"Neurology"},{"key":"BFEMMM201505079_CR41","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1012478","volume":"366","author":"WJ Koopman","year":"2012","unstructured":"Koopman WJ, Willems PH, Smeitink JA (2012) Monogenic mitochondrial disorders. N Engl J Med 366: 1132\u20131141","journal-title":"N Engl J Med"},{"key":"BFEMMM201505079_CR42","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.56.10.1409","volume":"56","author":"C Kornblum","year":"2001","unstructured":"Kornblum C, Broicher R, Walther E, Seibel P, Reichmann H, Klockgether T, Herberhold C, Schroder R (2001) Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology 56: 1409\u20131412","journal-title":"Neurology"},{"key":"BFEMMM201505079_CR43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ng.2501","volume":"45","author":"C Kornblum","year":"2013","unstructured":"Kornblum C, Nicholls TJ, Haack TB, Scholer S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A et\u00a0al (2013) Loss\u2010of\u2010function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nat Genet 45: 214\u2013219","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(99)05225-3","volume":"355","author":"JV Leonard","year":"2000","unstructured":"Leonard JV, Schapira AH (2000a) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355: 299\u2013304","journal-title":"Lancet"},{"key":"BFEMMM201505079_CR45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(99)05226-5","volume":"355","author":"JV Leonard","year":"2000","unstructured":"Leonard JV, Schapira AVH (2000b) Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355: 389\u2013394","journal-title":"Lancet"},{"key":"BFEMMM201505079_CR46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jmg.2003.016048","volume":"41","author":"A Limongelli","year":"2004","unstructured":"Limongelli A, Schaefer J, Jackson S, Invernizzi F, Kirino Y, Suzuki T, Reichmann H, Zeviani M (2004) Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNA(Ile) homoplasmic mutation in the mitochondrial genome. J Med Genet 41: 342\u2013349","journal-title":"J Med Genet"},{"key":"BFEMMM201505079_CR47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbabio.2004.05.003","volume":"1657","author":"R Lodi","year":"2004","unstructured":"Lodi R, Rajagopalan B, Blamire AM, Crilley JG, Styles P, Chinnery PF (2004) Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in\u00a0vivo using phosphorus MR spectroscopy. Biochim Biophys Acta 1657: 146\u2013150","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201505079_CR48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K et\u00a0al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364: 875\u2013882","journal-title":"Lancet"},{"key":"BFEMMM201505079_CR49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/301959","volume":"63","author":"K Majamaa","year":"1998","unstructured":"Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, Majamaa\u2010Volti KAM, Rusanen H, Sorri M, Peuhkurinen KJ et\u00a0al (1998) Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63: 447\u2013454","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"PY Man","year":"2003","unstructured":"Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF (2003) The epidemiology of leber hereditary optic neuropathy in the north East of England. Am J Hum Genet 72: 333\u2013339","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR51","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.WNL.0000028689.93049.9A","volume":"59","author":"M Mancuso","year":"2002","unstructured":"Mancuso M, Salviati L, Sacconi S, Otaegui D, Camano P, Marina A, Bacman S, Moraes CT, Carlo JR, Garcia M et\u00a0al (2002) Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology 59: 1197\u20131202","journal-title":"Neurology"},{"key":"BFEMMM201505079_CR52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng746","volume":"29","author":"H Mandel","year":"2001","unstructured":"Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M et\u00a0al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29: 337\u2013341","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng819","volume":"30","author":"R McFarland","year":"2002","unstructured":"McFarland R, Clark KM, Morris AA, Taylor RW, Macphail S, Lightowlers RN, Turnbull DM (2002) Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 30: 145\u2013146","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/112067210801800225","volume":"18","author":"A Nemes","year":"2008","unstructured":"Nemes A, De Coo IF, Spruijt L, Smeets HJ, Chinnery PF, Soliman OI, Geleijnse ML, Ten Cate FJ (2008) Is there alteration in aortic stiffness in Leber hereditary optic neuropathy? Eur J Ophthalmol 18: 309\u2013312","journal-title":"Eur J Ophthalmol"},{"key":"BFEMMM201505079_CR55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4414\/smw.2009.12390","volume":"139","author":"A Nemes","year":"2009","unstructured":"Nemes A, Geleijnse ML, Sluiter W, Vydt TC, Soliman OI, van Dalen BM, Vletter WB, ten Cate FJ, Smeets HJ, de Coo RF (2009) Aortic distensibility alterations in adults with m.3243A>G MELAS gene mutation. Swiss Med Wkly 139: 117\u2013120","journal-title":"Swiss Med Wkly"},{"key":"BFEMMM201505079_CR56","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp-2012-303528","volume":"84","author":"V Nesbitt","year":"2013","unstructured":"Nesbitt V, Pitceathly RD, Turnbull DM, Taylor RW, Sweeney MG, Mudanohwo EE, Rahman S, Hanna MG, McFarland R (2013) The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation\u2013implications for diagnosis and management. J Neurol Neurosurg Psychiatry 84: 936\u2013938","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFEMMM201505079_CR57","doi-asserted-by":"publisher","unstructured":"Ng YS, Grady JP, Lax NZ, Bourke JP, Alston CL, Hardy SA, Falkous G, Schaefer AG, Radunovic A, Mohiddin SA et\u00a0al (2015) Sudden adult death syndrome in m.3243A>G\u2010related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults. Eur Heart J doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehv306","DOI":"10.1093\/eurheartj\/ehv306"},{"key":"BFEMMM201505079_CR58","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(94)92830-4","volume":"344","author":"EK Nikoskelainen","year":"1994","unstructured":"Nikoskelainen EK, Savontaus ML, Huoponen K, Antila K, Hartiala J (1994) Pre\u2010excitation syndrome in Leber's hereditary optic neuropathy. Lancet 344: 857\u2013858","journal-title":"Lancet"},{"key":"BFEMMM201505079_CR59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","volume":"283","author":"I Nishino","year":"1999","unstructured":"Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689\u2013692","journal-title":"Science"},{"key":"BFEMMM201505079_CR60","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbabio.2015.05.022","volume":"1847","author":"BA Payne","year":"2015","unstructured":"Payne BA, Chinnery PF (2015) Mitochondrial dysfunction in aging: much progress but many unresolved questions. Biochim Biophys Acta 1847: 1347\u20131353","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201505079_CR61","first-page":"CD004426","volume":"4","author":"G Pfeffer","year":"2012","unstructured":"Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF (2012) Treatment for mitochondrial disorders. Cochrane Database Syst Rev 4: CD004426","journal-title":"Cochrane Database Syst Rev"},{"key":"BFEMMM201505079_CR62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","volume":"9","author":"G Pfeffer","year":"2013","unstructured":"Pfeffer G, Horvath R, Klopstock T, Mootha VK, Suomalainen A, Koene S, Hirano M, Zeviani M, Bindoff LA, Yu\u2010Wai\u2010Man P et\u00a0al (2013) New treatments for mitochondrial disease\u2010no time to drop our standards. Nat Rev Neurol 9: 474\u2013481","journal-title":"Nat Rev Neurol"},{"key":"BFEMMM201505079_CR63","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/brain\/awu060","volume":"137","author":"G Pfeffer","year":"2014","unstructured":"Pfeffer G, Gorman GS, Griffin H, Kurzawa\u2010Akanbi M, Blakely EL, Wilson I, Sitarz K, Moore D, Murphy JL, Alston CL et\u00a0al (2014) Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain 137: 1323\u20131336","journal-title":"Brain"},{"key":"BFEMMM201505079_CR64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","volume":"84","author":"G Pfeffer","year":"2015","unstructured":"Pfeffer G, Pyle A, Griffin H, Miller J, Wilson V, Turnbull L, Fawcett K, Sims D, Eglon G, Hadjivassiliou M et\u00a0al (2015) SPG7 mutations are a common cause of undiagnosed ataxia. Neurology 84: 1174\u20131176","journal-title":"Neurology"},{"key":"BFEMMM201505079_CR65","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/brain\/aws231","volume":"135","author":"RD Pitceathly","year":"2012","unstructured":"Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z et\u00a0al (2012) Adults with RRM2B\u2010related mitochondrial disease have distinct clinical and molecular characteristics. Brain 135: 3392\u20133403","journal-title":"Brain"},{"key":"BFEMMM201505079_CR66","doi-asserted-by":"crossref","first-page":"e1001066","DOI":"10.1371\/journal.pgen.1001066","volume":"6","author":"J Poulton","year":"2010","unstructured":"Poulton J, Chiaratti MR, Meirelles FV, Kennedy S, Wells D, Holt IJ (2010) Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet 6: e1001066","journal-title":"PLoS Genet"},{"key":"BFEMMM201505079_CR67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11064-006-9190-z","volume":"32","author":"CM Quinzii","year":"2007","unstructured":"Quinzii CM, DiMauro S, Hirano M (2007) Human coenzyme Q10 deficiency. Neurochem Res 32: 723\u2013727","journal-title":"Neurochem Res"},{"key":"BFEMMM201505079_CR68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2010.06.001","volume":"87","author":"LG Riley","year":"2010","unstructured":"Riley LG, Cooper S, Hickey P, Rudinger\u2010Thirion J, McKenzie M, Compton A, Lim SC, Thorburn D, Ryan MT, Giege R et\u00a0al (2010) Mutation of the mitochondrial tyrosyl\u2010tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia\u2013MLASA syndrome. Am J Hum Genet 87: 52\u201359","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ajhg.2012.12.014","volume":"92","author":"D Ronchi","year":"2013","unstructured":"Ronchi D, Di Fonzo A, Lin W, Bordoni A, Liu C, Fassone E, Pagliarani S, Rizzuti M, Zheng L, Filosto M et\u00a0al (2013) Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am J Hum Genet 92: 293\u2013300","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201505079_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabet.2009.11.002","volume":"36","author":"A Rotig","year":"2010","unstructured":"Rotig A (2010) Genetic bases of mitochondrial respiratory chain disorders. Diabetes Metab 36: 97\u2013107","journal-title":"Diabetes Metab"},{"key":"BFEMMM201505079_CR71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","volume":"29","author":"A Saada","year":"2001","unstructured":"Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29: 342\u2013344","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR72","first-page":"138","volume":"23","author":"D Skladal","year":"2000","unstructured":"Skladal D, Bernier FP, Halliday JL, Thorburn DR (2000) Birth prevalence of mitochondrial respiratory chain defects in children. J Inher Metab Dis 23: 138","journal-title":"J Inher Metab Dis"},{"key":"BFEMMM201505079_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/90058","volume":"28","author":"JN Spelbrink","year":"2001","unstructured":"Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L et\u00a0al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4\u2010like protein localized in mitochondria. Nat Genet 28: 223\u2013231","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR74","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/brain\/aws070","volume":"135","author":"ME Steenweg","year":"2012","unstructured":"Steenweg ME, Ghezzi D, Haack T, Abbink TE, Martinelli D, van Berkel CG, Bley A, Diogo L, Grillo E, Te Water Naude J et\u00a0al (2012) Leukoencephalopathy with thalamus and brainstem involvement and high lactate \u201cLTBL\u201d caused by EARS2 mutations. Brain 135: 1387\u20131394","journal-title":"Brain"},{"key":"BFEMMM201505079_CR75","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen A, Elo JM, Pietilainen KH, Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK, Tyni T, Kiuru\u2010Enari S et\u00a0al (2011) FGF\u201021 as a biomarker for muscle\u2010manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 10: 806\u2013818","journal-title":"Lancet Neurol"},{"key":"BFEMMM201505079_CR76","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0735-1097(03)00300-0","volume":"41","author":"RW Taylor","year":"2003","unstructured":"Taylor RW, Giordano C, Davidson MM, d'Amati G, Bain H, Hayes CM, Leonard H, Barron MJ, Casali C, Santorelli FM et\u00a0al (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41: 1786\u20131796","journal-title":"J Am Coll Cardiol"},{"key":"BFEMMM201505079_CR77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2014.7184","volume":"312","author":"RW Taylor","year":"2014","unstructured":"Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A et\u00a0al (2014) Use of whole\u2010exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA 312: 68\u201377","journal-title":"JAMA"},{"key":"BFEMMM201505079_CR78","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/hmg\/9.18.2733","volume":"9","author":"V Tiranti","year":"2000","unstructured":"Tiranti V, Corona P, Greco M, Taanman JW, Carrara F, Lamantea E, Nijtmans L, Uziel G, Zeviani M (2000) A novel frameshift mutation of the mtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patient affected by Leigh\u2010like syndrome. Hum Mol Genet 9: 2733\u20132742","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201505079_CR79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ana.24185","volume":"76","author":"C Tzoulis","year":"2014","unstructured":"Tzoulis C, Tran GT, Coxhead J, Bertelsen B, Lilleng PK, Balafkan N, Payne B, Miletic H, Chinnery PF, Bindoff LA (2014) Molecular pathogenesis of polymerase gamma\u2010related neurodegeneration. Ann Neurol 76: 66\u201381","journal-title":"Ann Neurol"},{"key":"BFEMMM201505079_CR80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/90034","volume":"28","author":"G Van Goethem","year":"2001","unstructured":"Van Goethem G, Dermaut B, Lofgren A, Martin J\u2010J, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28: 211\u2013212","journal-title":"Nat Genet"},{"key":"BFEMMM201505079_CR81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2006.07.089","volume":"99","author":"TC Vydt","year":"2007","unstructured":"Vydt TC, de Coo RF, Soliman OI, Ten Cate FJ, van Geuns RJ, Vletter WB, Schoonderwoerd K, van den Bosch BJ, Smeets HJ, Geleijnse ML (2007) Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 99: 264\u2013269","journal-title":"Am J Cardiol"},{"key":"BFEMMM201505079_CR82","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJD, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427\u20131430","journal-title":"Science"},{"key":"BFEMMM201505079_CR83","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","volume":"117","author":"P Yu\u2010Wai\u2010Man","year":"2010","unstructured":"Yu\u2010Wai\u2010Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah\u2010Kine D, Hudson G, Czermin B, Taylor RW et\u00a0al (2010a) The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 117: 1538\u20131546, 1546 e1","journal-title":"Ophthalmology"},{"key":"BFEMMM201505079_CR84","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu\u2010Wai\u2010Man","year":"2010","unstructured":"Yu\u2010Wai\u2010Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer\u2010Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L et\u00a0al (2010b) Multi\u2010system neurological disease is common in patients with OPA1 mutations. Brain 133: 771\u2013786","journal-title":"Brain"},{"key":"BFEMMM201505079_CR85","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/hmg\/ddq209","volume":"19","author":"P Yu\u2010Wai\u2010Man","year":"2010","unstructured":"Yu\u2010Wai\u2010Man P, Sitarz KS, Samuels DC, Griffiths PG, Reeve AK, Bindoff LA, Horvath R, Chinnery PF (2010c) OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild\u2010type mtDNA molecules. Hum Mol Genet 19: 3043\u20133052","journal-title":"Hum Mol Genet"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201505079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201505079","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201505079\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201505079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201505079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:15:51Z","timestamp":1779084951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201505079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12,1]]}},"alternative-id":["BFEMMM201505079"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201505079","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]},"assertion":[{"value":"7 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author was Chief Investigator for the Santhera Pharmaceuticals sponsored trial Rescue of Hereditary Optic Disease Outpatient Study (NCT00747487), but has remained an independent academic investigator throughout. He currently has a collaborative research project with GlaxoSmithKline on the natural history of mitochondrial disease. He has no conflict of interest with the work described in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}